Literature DB >> 19242414

Learning therapeutic lessons from metastasis suppressor proteins.

Steven Christopher Smith1, Dan Theodorescu.   

Abstract

Metastasis suppressor proteins regulate multiple steps in the metastatic cascade, including cancer cell invasion, survival in the vascular and lymphatic circulation, and colonization of distant organ sites. Understanding the biology of metastasis suppressors provides valuable mechanistic insights that may translate to therapeutic opportunities. Several reports have explored novel strategies for restoring metastasis suppressor function, including gene transfer, induction of previously suppressed gene expression and exogenous administration of gene product. Pathways activated downstream of metastasis suppressor loss can also be targeted. Although none of these strategies are yet in routine clinical use, several are being tested preclinically and in clinical trials.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19242414      PMCID: PMC2881216          DOI: 10.1038/nrc2594

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  125 in total

1.  Snail is a repressor of RKIP transcription in metastatic prostate cancer cells.

Authors:  S Beach; H Tang; S Park; A S Dhillon; E T Keller; W Kolch; K C Yeung
Journal:  Oncogene       Date:  2007-10-22       Impact factor: 9.867

Review 2.  Gene delivery for lung cancer using nonviral gene vectors.

Authors:  J T Wang; D Y Peng; M Chen; J S Ye
Journal:  Pharmazie       Date:  2007-10       Impact factor: 1.267

3.  Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia.

Authors:  Y Wu; K McRoberts; S S Berr; H F Frierson; M Conaway; D Theodorescu
Journal:  Oncogene       Date:  2006-07-31       Impact factor: 9.867

4.  Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix.

Authors:  Bedrich L Eckhardt; Belinda S Parker; Ryan K van Laar; Christina M Restall; Anthony L Natoli; Michael D Tavaria; Kym L Stanley; Erica K Sloan; Jane M Moseley; Robin L Anderson
Journal:  Mol Cancer Res       Date:  2005-01       Impact factor: 5.852

5.  The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells.

Authors:  Steve Goodison; Jing Yuan; Derek Sloan; Ryung Kim; Cheng Li; Nicholas C Popescu; Virginia Urquidi
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

6.  E-cadherin gene mutations provide clues to diffuse type gastric carcinomas.

Authors:  K F Becker; M J Atkinson; U Reich; I Becker; H Nekarda; J R Siewert; H Höfler
Journal:  Cancer Res       Date:  1994-07-15       Impact factor: 12.701

Review 7.  Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site.

Authors:  Eric C Kauffman; Victoria L Robinson; Walter M Stadler; Mitchell H Sokoloff; Carrie W Rinker-Schaeffer
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

Review 8.  Metastasis suppressors genes in cancer.

Authors:  Lewis J Stafford; Kedar S Vaidya; Danny R Welch
Journal:  Int J Biochem Cell Biol       Date:  2008-01-15       Impact factor: 5.085

9.  Systemic spread is an early step in breast cancer.

Authors:  Yves Hüsemann; Jochen B Geigl; Falk Schubert; Piero Musiani; Manfred Meyer; Elke Burghart; Guido Forni; Roland Eils; Tanja Fehm; Gert Riethmüller; Christoph A Klein
Journal:  Cancer Cell       Date:  2008-01       Impact factor: 31.743

10.  BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process.

Authors:  Pushkar A Phadke; Kedar S Vaidya; Kevin T Nash; Douglas R Hurst; Danny R Welch
Journal:  Am J Pathol       Date:  2008-02-14       Impact factor: 4.307

View more
  84 in total

1.  RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration.

Authors:  Neveen Said; Marta Sanchez-Carbayo; Steven C Smith; Dan Theodorescu
Journal:  J Clin Invest       Date:  2012-03-12       Impact factor: 14.808

Review 2.  Targeted therapies for adrenocortical carcinoma: IGF and beyond.

Authors:  Michael J Demeure; Kimberly J Bussey; Lawrence S Kirschner
Journal:  Horm Cancer       Date:  2011-12       Impact factor: 3.869

3.  Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties.

Authors:  Thomas J Bartosh; Joni H Ylöstalo; Arezoo Mohammadipoor; Nikolay Bazhanov; Katie Coble; Kent Claypool; Ryang Hwa Lee; Hosoon Choi; Darwin J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-19       Impact factor: 11.205

4.  SDPR functions as a metastasis suppressor in breast cancer by promoting apoptosis.

Authors:  Sait Ozturk; Panagiotis Papageorgis; Chen Khuan Wong; Arthur W Lambert; Hamid M Abdolmaleky; Arunthathi Thiagalingam; Herbert T Cohen; Sam Thiagalingam
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-06       Impact factor: 11.205

5.  CTHRC1 is upregulated by promoter demethylation and transforming growth factor-β1 and may be associated with metastasis in human gastric cancer.

Authors:  Ping Wang; Ying-Chao Wang; Xiao-Yu Chen; Zhi-Yong Shen; Hui Cao; Yan-Jie Zhang; Jian Yu; Jing-De Zhu; You-Yong Lu; Jing-Yuan Fang
Journal:  Cancer Sci       Date:  2012-05-17       Impact factor: 6.716

6.  Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancer.

Authors:  Neveen Said; Steven Smith; Marta Sanchez-Carbayo; Dan Theodorescu
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

Review 7.  Rethinking the metastatic cascade as a therapeutic target.

Authors:  Lida A Mina; George W Sledge
Journal:  Nat Rev Clin Oncol       Date:  2011-04-19       Impact factor: 66.675

8.  In vitro metastatic colonization of human ovarian cancer cells to the omentum.

Authors:  Shaheena M Khan; Holly M Funk; Sophie Thiolloy; Tamara L Lotan; Jonathan Hickson; Gail S Prins; Angela F Drew; Carrie W Rinker-Schaeffer
Journal:  Clin Exp Metastasis       Date:  2010-03-14       Impact factor: 5.150

Review 9.  Protein-protein interactions: a mechanism regulating the anti-metastatic properties of Nm23-H1.

Authors:  Natascia Marino; Jean-Claude Marshall; Patricia S Steeg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-06-29       Impact factor: 3.000

10.  The metastasis suppressor NME1 inhibits melanoma cell motility via direct transcriptional induction of the integrin beta-3 gene.

Authors:  M Kathryn Leonard; Marián Novak; Devin Snyder; Grace Snow; Nidhi Pamidimukkala; Joseph R McCorkle; Xiuwei H Yang; David M Kaetzel
Journal:  Exp Cell Res       Date:  2018-11-17       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.